ClinicalTrials.Veeva

Menu

Human Epididymis Protein 4 in Women With Severe Preeclampsia / HELLP Syndrome

A

Ain Shams University

Status

Unknown

Conditions

Preeclampsia

Treatments

Diagnostic Test: Human epididymis protein 4

Study type

Observational

Funder types

Other

Identifiers

NCT03891394
ainshamHE4

Details and patient eligibility

About

Pre-eclampsia seems to be associated with a four to five times increase risk of later microalbuminuria and CKD which might suggest a possible direct renal damage from pre-eclampsia

Enrollment

110 estimated patients

Sex

Female

Ages

18 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Pregnant women 18-35 years old.
  2. Fulfilling the criteria for diagnosis of sever preeclampsia.
  3. Fulfilling the criteria for diagnosis of HELLP syndrome

Exclusion criteria

  1. Diabetes mellitus
  2. Preexisting renal disease.
  3. Chronic hypertension
  4. Rheumatologic diseases
  5. Adnexal mass.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems